This article was originally published by HCPLive. The American College of Rheumatology (ACR) released 2 clinical practice guidelines for the screening, monitoring, and treatment of interstitial lung ...

Please provide your email address to receive an email when new articles are posted on . Newly announced ACR guidelines recommend against glucocorticoids as first-line therapy for interstitial lung ...

EULAR—The European Alliance of Associations for Rheumatology—has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) ...

A CHEST project hopes to educate health care workers on best practices in interstitial lung disease diagnosis. This project draws attention to how health inequities impact diagnosis. Increasing health ...

BARCELONA, Spain — The JAK inhibitor upadacitinib can effectively treat systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to results from a new clinical trial. Patients ...

The FDA has approved YUTREPIA™ (treprostinil) inhalation powder, developed by Liquidia Corporation, as a treatment option for adults with pulmonary arterial hypertension (PAH) and pulmonary ...

WHAT IS INTERSTITIAL LUNG DISEASE? Overview of Interstitial Lung Disease (ILD):Interstitial Lung Disease refers to a group of lung conditions that cause inflammation and scarring of the ...

Orphan drug designation from Japan’s Ministry of Health, Labour and Welfare provides key regulatory benefits, including priority review and extended market exclusivity for potential treatments ...

Clinical practice guidelines would help to standardize screening, diagnosis, treatment, and follow-up for patients with CTD-ILD. To address this gap, EULAR and the ERS formed a task force - including ...